Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 14.05%1.62B | 37.38%2.72B | 19.08%1.42B | -13.21%1.98B | 6.90%1.19B | 21.98%2.28B | 8.89%1.12B | 90.86%1.87B | 25.32%1.03B | -19.94%979.13M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -3.34%-83.94M | 3.49%-147.78M | 38.44%-81.22M | -2.43%-153.12M | -178.13%-131.95M | -100.79%-149.49M | -2.96%-47.44M | -55.12%-74.45M | -25.23%-46.08M | 42.77%-47.99M |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | -18.30%23.34M | ---- | --28.57M | ---- | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.01M | ---4.02M | ---- |
| Investment loss (gain) | ---- | ---- | ---- | -3,659.19%-48.27M | ---47.07M | ---1.28M | ---- | ---- | ---- | -7,689.53%-6.53M |
| Attributable subsidiary (profit) loss | -150.70%-22.93M | -1,271.11%-348.93M | 328.24%45.23M | -13.00%29.8M | -17.17%10.56M | -7.69%34.25M | -22.00%12.75M | 22.07%37.1M | -8.96%16.35M | 175.52%30.39M |
| Impairment and provisions: | -34.46%3.51M | 189.34%47.09M | 225.14%5.35M | -116.17%-52.71M | -104.16%-4.28M | 2.88%325.91M | 1,181.43%102.82M | 2,738.65%316.79M | -220.80%-9.51M | -74.24%11.16M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --183.03M | ---- | ---- |
| -Impairmen of inventory (reversal) | -577.59%-277K | 101.37%378K | -98.44%58K | -195.98%-27.54M | -81.85%3.73M | 841.75%28.69M | 518.56%20.52M | -205.97%-3.87M | -1,389.97%-4.9M | 142.20%3.65M |
| -Impairment of trade receivables (reversal) | -341.93%-1.93M | 117.93%2.63M | 108.46%799K | -292.37%-14.67M | ---9.44M | 42.12%7.63M | ---- | 510.47%5.37M | -41.44%4.01M | -94.54%879K |
| -Other impairments and provisions | 27.21%5.72M | 519.73%44.08M | 212.08%4.49M | -103.63%-10.5M | -98.25%1.44M | 118.94%289.59M | 1,055.25%82.3M | 1,894.66%132.27M | -737.28%-8.62M | -74.22%6.63M |
| Revaluation surplus: | -562.53%-257.01M | -20.77%284.07M | -76.07%55.57M | 250.66%358.55M | 1,781.42%232.19M | -883.20%-237.98M | ---13.81M | ---24.21M | ---- | ---- |
| -Other fair value changes | -562.53%-257.01M | -20.77%284.07M | -76.07%55.57M | 250.66%358.55M | 1,781.42%232.19M | -883.20%-237.98M | ---13.81M | ---24.21M | ---- | ---- |
| Asset sale loss (gain): | -55.00%5.64M | 703.25%15.08M | 817.50%12.53M | 122.39%1.88M | 28.02%1.37M | 131.20%844K | 106.63%1.07M | -791.82%-2.71M | -980.46%-16.09M | -88.39%391K |
| -Loss (gain) from sale of subsidiary company | ---2.61M | ---- | ---- | ---- | ---- | 79.00%-3.49M | ---- | -2,555.52%-16.6M | -2,557.60%-16.61M | ---625K |
| -Loss (gain) on sale of property, machinery and equipment | -33.51%8.33M | 703.25%15.08M | 817.50%12.53M | -56.64%1.88M | 28.02%1.37M | -68.84%4.33M | 103.63%1.07M | 1,267.32%13.89M | -78.63%524K | -69.82%1.02M |
| -Loss (gain) from selling other assets | ---79K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 23.03%241.7M | 17.40%412.62M | 9.44%196.46M | -11.73%351.46M | -11.52%179.5M | 156.39%398.16M | 22.70%202.87M | -57.72%155.3M | -6.86%165.33M | 8.76%367.32M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.05%185.52M |
| -Amortization of intangible assets | 8.39%57.84M | 5.69%109.79M | 1.69%53.36M | -36.01%103.87M | -32.44%52.47M | 31.59%162.32M | 29.85%77.67M | -21.21%123.35M | -19.51%59.81M | 15.91%156.55M |
| -Other depreciation and amortization | -21.83%7.09M | 6.38%17.67M | 16.19%9.07M | -41.46%16.61M | -64.44%7.81M | 204.44%28.38M | 291.12%21.95M | 46.09%9.32M | 88.54%5.61M | 68.81%6.38M |
| Financial expense | -49.21%53M | -10.10%190.85M | 59.23%104.35M | 106.62%212.3M | 724.95%65.53M | 54.45%102.75M | -75.43%7.94M | -17.94%66.53M | -25.88%32.33M | -25.95%81.07M |
| Exchange Loss (gain) | 21.31%-9.52M | -135.14%-25.28M | 17.55%-12.09M | 126.19%71.93M | 94.16%-14.67M | -103.43%-274.64M | -337.11%-251.08M | -154.00%-135.01M | -1,098.69%-57.44M | 625.02%250.03M |
| Special items | 308.33%44.43M | 88.03%-4.13M | -121.82%-21.33M | -22.59%-34.48M | -1.75%-9.62M | -332.54%-28.13M | -1,459.41%-9.45M | -102.76%-6.5M | 95.29%-606K | -21.94%235.5M |
| Operating profit before the change of operating capital | -7.54%1.6B | 15.68%3.14B | 15.19%1.73B | 10.85%2.72B | 30.21%1.5B | 11.48%2.45B | 4.08%1.15B | 15.64%2.2B | 9.21%1.11B | 0.12%1.9B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -143.14%-107.35M | 51.61%-18.03M | -42.39%-44.15M | 23.50%-37.26M | 68.21%-31.01M | 27.46%-48.71M | -70.83%-97.52M | 27.89%-67.15M | -52.93%-57.09M | 25.42%-93.11M |
| Accounts receivable (increase)decrease | -21.45%-183.61M | -191.92%-212.66M | -812.52%-151.19M | 280.47%231.34M | -108.20%-16.57M | 115.16%60.8M | 182.41%202.02M | -1,250.27%-401.16M | -46.33%-245.14M | -92.32%34.88M |
| Accounts payable increase (decrease) | 208.42%80.28M | 29.96%301.92M | 0.73%-74.05M | 539.16%232.32M | 48.32%-74.59M | -81.37%36.35M | -437.43%-144.32M | 1,329.13%195.06M | 393.14%42.77M | -117.42%-15.87M |
| prepayments (increase)decrease | -361.33%-197.89M | 178.07%476.11M | -542.77%-42.9M | -5,453.54%-609.88M | -81.40%9.69M | 247.07%11.39M | -30.92%52.08M | 93.99%-7.75M | 1,223.97%75.39M | -95.55%-128.87M |
| Special items for working capital changes | -28.07%13.45M | -15.24%18.17M | -1.26%18.7M | 173.48%21.44M | -42.50%18.94M | 43.29%-29.18M | 145.97%32.94M | 47.97%-51.44M | 387.71%13.39M | -913.95%-98.88M |
| Cash from business operations | -16.17%1.2B | 45.17%3.71B | 1.97%1.43B | 2.95%2.55B | 17.47%1.41B | 33.00%2.48B | 27.90%1.2B | 16.67%1.87B | 19.61%935.46M | -28.72%1.6B |
| Other taxs | 31.88%-231.9M | -7.44%-505.92M | -54.06%-340.42M | -35.95%-470.9M | -30.86%-220.97M | -20.76%-346.37M | -36.22%-168.86M | -12.90%-286.82M | -67.85%-123.96M | 28.50%-254.05M |
| Net cash from operations | -11.27%969.56M | 53.70%3.2B | -7.75%1.09B | -2.41%2.08B | 15.27%1.18B | 35.22%2.13B | 26.63%1.03B | 17.39%1.58B | 14.58%811.5M | -28.76%1.34B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -50.24%12.32M | -29.68%84.11M | -80.70%24.77M | -13.62%119.61M | 125.58%128.35M | 56.32%138.47M | 32.35%56.9M | 152.68%88.58M | 75.35%42.99M | -48.66%35.06M |
| Dividend received - investment | ---- | --446.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | 4.61%3.11M | -19,436.57%-77.73M | -6.10%2.97M | -98.16%402K | 1.54%3.16M | 149.99%21.79M | 105.08%3.12M | -516.22%-43.6M | -971.52%-61.29M | -96.03%10.47M |
| Decrease in deposits (increase) | -3,400.45%-452.59M | 106.58%122.66M | 103.86%13.71M | -831.57%-1.86B | -266.68%-355.46M | ---200M | ---96.94M | ---- | ---- | ---- |
| Sale of fixed assets | 12.72%3.39M | -44.25%8.58M | 144.32%3.01M | 3,633.50%15.38M | 40.64%1.23M | -73.84%412K | 427.71%876K | -40.14%1.58M | -8.79%166K | 30.25%2.63M |
| Purchase of fixed assets | 63.23%-88.63M | -9.11%-681.64M | 25.45%-241.06M | 31.40%-624.72M | -20.06%-323.34M | 11.52%-910.61M | 42.51%-269.31M | -15.24%-1.03B | -51.18%-468.47M | -89.43%-892.99M |
| Purchase of intangible assets | 41.29%-67.54M | -253.69%-281.6M | -169.26%-115.05M | -24.08%-79.62M | 21.24%-42.73M | 44.99%-64.17M | 12.59%-54.25M | -31.83%-116.65M | -141.42%-62.07M | -495.80%-88.49M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5M | ---- |
| Recovery of cash from investments | 448.97%5.4B | -37.10%3.15B | -73.11%983.13M | -63.69%5B | -46.53%3.66B | 63.61%13.78B | 119.99%6.84B | 26.42%8.43B | -59.79%3.11B | -36.94%6.66B |
| Cash on investment | -251.72%-4.54B | -5.14%-4.14B | 71.20%-1.29B | 76.21%-3.94B | 45.96%-4.48B | -89.79%-16.55B | -146.67%-8.29B | -13.23%-8.72B | 58.40%-3.36B | 33.32%-7.7B |
| Other items in the investment business | ---- | -34.14%12.05M | ---- | -67.11%18.29M | 25,109.43%13.36M | -48.22%55.61M | -99.82%53K | 7.34%107.39M | 322.03%30.22M | 15,508.11%100.05M |
| Net cash from investment operations | 143.42%268.72M | -0.92%-1.36B | 55.79%-618.89M | 63.86%-1.35B | 22.74%-1.4B | -189.39%-3.72B | -136.51%-1.81B | 31.18%-1.29B | -16.51%-766M | -64.90%-1.87B |
| Net cash before financing | 161.34%1.24B | 149.97%1.84B | 320.06%473.82M | 146.42%737.5M | 72.54%-215.31M | -644.40%-1.59B | -1,823.38%-784.1M | 155.59%291.83M | -10.36%45.5M | -169.65%-524.92M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 41.62%2.1B | -23.01%1.53B | -9.63%1.48B | -6.61%1.99B | 12.68%1.64B | 689.09%2.13B | 797.28%1.46B | -46.17%270.16M | -64.87%162.3M | -59.20%501.82M |
| Refund | -25.60%-2.6B | -248.22%-2.8B | -581.59%-2.07B | -294.30%-803.24M | -102.63%-303.94M | 44.03%-203.71M | 58.33%-150M | 38.25%-363.95M | 26.44%-360M | 66.14%-589.4M |
| Issuing shares | --27.97M | ---- | ---- | 99.41%337K | --337K | -95.91%169K | ---- | -99.84%4.13M | -99.84%4.13M | 35,262.97%2.52B |
| Issuance of bonds | ---- | ---- | ---- | --1.2B | --1.2B | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 69.17%-38.6M | -43.00%-175.09M | -114.65%-125.19M | -159.09%-122.44M | -533.10%-58.32M | -654.66%-47.26M | -493.56%-9.21M | 96.81%-6.26M | 77.29%-1.55M | -412.81%-196.08M |
| Dividends paid - financing | -80.00%-10.61M | -146.83%-555.09M | ---5.9M | 46.09%-224.88M | ---- | ---417.14M | ---- | ---- | ---- | ---- |
| Absorb investment income | --2.5M | -44.00%2.8M | ---- | -65.03%5M | ---- | -71.41%14.3M | --2.3M | -97.12%50M | ---- | 1,101.40%1.73B |
| Issuance expenses and redemption of securities expenses | -394.95%-1.2B | 89.80%-242.45M | 89.78%-242.45M | -237.99%-2.38B | ---2.37B | -70.39%-703.55M | ---- | 82.84%-412.9M | ---- | -6,200.28%-2.41B |
| Pledged bank deposit (increase) decrease | 3,399.68%30.89M | 84.59%-1.31M | 78.82%-936K | -257.75%-8.48M | -148.00%-4.42M | 173.38%5.38M | 1,529.73%9.21M | -50.41%-7.33M | -87.51%565K | -347.46%-4.87M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---475.68M | ---- | ---- | ---- |
| Net cash from financing operations | -74.95%-1.7B | -538.39%-2.25B | -1,153.55%-972.82M | -146.25%-352.98M | -88.77%92.34M | 258.63%763.22M | 505.11%822.17M | -131.03%-481.12M | -112.37%-202.95M | 441.26%1.55B |
| Effect of rate | 267.02%45.03M | -178.37%-58.69M | -163.06%-26.96M | -31.30%74.89M | 82.18%42.75M | 425.71%109.01M | 271.24%23.47M | -88.26%-33.47M | -172.80%-13.7M | -96.99%-17.78M |
| Net Cash | 7.07%-463.7M | -206.58%-409.82M | -305.77%-498.99M | 146.58%384.53M | -423.10%-122.97M | -336.11%-825.51M | 124.17%38.06M | -118.45%-189.29M | -109.31%-157.45M | 242.76%1.03B |
| Begining period cash | -17.94%2.14B | 21.35%2.61B | 21.35%2.61B | -24.98%2.15B | -24.98%2.15B | -7.20%2.87B | -7.20%2.87B | 48.39%3.09B | 48.39%3.09B | 16.19%2.08B |
| Cash at the end | -17.32%1.72B | -17.94%2.14B | 0.66%2.09B | 21.35%2.61B | -29.29%2.07B | -24.98%2.15B | 0.35%2.93B | -7.21%2.87B | -23.03%2.92B | 48.39%3.09B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.